Tazorac (tazarotene recalls
The FDA has published 4 recalls involving Tazorac (tazarotene since 2016. The latest was reported on 19 Oct 2016. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 19 Oct 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why tazorac (tazarotene is recalled
Companies
By year
All tazorac (tazarotene recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tazorac (tazarotene) Gel recalled by Allergan Sales | Allergan Sales | Packaging Defects | Nationwide |
| Drug | CLASS II | Tazorac (tazarotene) Gel recalled by Allergan Sales | Allergan Sales | Packaging Defects | Nationwide |
| Drug | CLASS II | Tazorac (tazarotene) Gel 0.05%, ., sample packs recalled | Allergan Sales | Other | Nationwide |
| Drug | CLASS II | Tazorac (tazarotene) Gel recalled by Allergan Sales | Allergan Sales | Packaging Defects | Nationwide |
Should you stop taking Tazorac (tazarotene?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.